Alphabet Inc., 10% Owner at Prime Medicine, Inc. (PRME), sold 85,283 shares at $13.66 ($728K) on 2023-05-24, disclosed to the SEC on 2023-05-26.
Scheduled sale ($728k) by 10% Owner under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 7,900 | $0 | 0.0% |
| 2 | $13.66 | 7,900 | $108K | 14.8% |
| 3 | $0.00 | 23,161 | $0 | 0.0% |
| 4 | $13.38 | 23,161 | $310K | 42.6% |
| 5 | $13.38 | 23,161 | $310K | 42.6% |
| Total | $8.53 avg | 85,283 |
| $728K |
| 100% |
| Filing → |
| PRME | SELL | 2023-06-20 | $2.2M | — | Filing → |
| PRME | SELL | 2023-05-24 | $3.8M | — | Filing → |
| GTLB | BUY | 2023-05-09 | $393K | — | Filing → |